Tag: licensing
-
Tissue Chip Experiments Set for Space Station
A collection of 4 new tissue chip experiments are among the payloads to be sent next week to the International Space Station or ISS.
-
Leaf-Based Process Produces Low-Cost Enzymes
A University of Pennsylvania lab is developing a process for producing enzymes, chemicals from organisms that act as catalysts, in green leafy plants at low cost.
-
Patent Awarded for Engineered T-Cell Cancer Therapy
An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent.
-
Start-Up Analyzes Images to Determine Medical Condition
A new company provides a service that determines a person’s condition for disease treatments based on indicators derived from an analysis of huge medical-image databases.
-
Biotechs Partner on Gene Silencing in $1.1B Deal
Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions.
-
Biotechs Join Forces for Off-the-Shelf Stem Cells
Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies.
-
Start-Up Creating Off-the-Shelf Stem Cell Therapies
A new company is licensing technology from the lab of its co-founder at Harvard University to develop stem cell therapies for any recipients, without causing immune reactions.
-
Crispr Diagnostics Company Launches with $35M Funding
Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing.
-
Spin-Off Producing Commercial-Grade Graphene
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics.
-
Start-Up Creating Touch Sensing for Visual Images
A start-up company spun off from Purdue University is developing a system that translates visual images to touch-sensing signals for people with limited visual abilities.